Gastroenterology and Hepatology

Hepatocellular Carcinoma (HCC): Early Detection and Management

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, often associated with chronic liver diseases, such as chronic hepatitis B, hepatitis C, and non-alcoholic fatty liver disease (NAFLD). Due to the liver's ability to compensate for damage, HCC is frequently diagnosed at an advanced stage when treatment options are limited. However, early detection significantly improves prognosis, making timely screening and management essential.

Early detection of HCC is crucial for effective treatment. Screening is particularly recommended for high-risk individuals, such as those with cirrhosis, chronic hepatitis B or C, and other liver diseases. Imaging techniques like ultrasound are commonly used for initial screening, often supplemented by alpha-fetoprotein (AFP) testing, a biomarker that may be elevated in the presence of HCC. Additionally, contrast-enhanced ultrasound, CT scans, and MRI can be used for further evaluation to assess the size, location, and vascular characteristics of the tumor.

Management of HCC:

Once diagnosed, the management of HCC depends on the tumor's size, location, and the underlying liver function. Surgical resection is the most effective treatment for early-stage HCC, providing the best chance for long-term survival. However, many patients are not candidates for surgery due to cirrhosis or advanced liver disease. In these cases, liver transplantation may be considered, especially for patients with early-stage HCC and underlying cirrhosis.